Supplement Material
Jujube Camp
Finished Product
Fermented Drinks
FSMP
Sports Nutrition Supplements
PKU Health Care Activities
CKD Health Care Activities
Leave Your Message
Our professionally formulated oral liquid suspension products are optimized for efficacy, palatability, and compliance with European pharmaceutical and nutraceutical standards.
Poland's pharmaceutical and nutraceutical sector is one of the fastest-growing in Central and Eastern Europe, creating substantial demand for high-quality oral suspension formulations across multiple healthcare segments.
Poland hosts over 14,000 pharmacies and a well-established network of hospital formularies. The country ranks among the top EU pharmaceutical markets by value, with oral suspension products in constant clinical and retail demand — especially for pediatric, geriatric, and post-surgical patient groups.
Polish consumers show strong and growing interest in preventive health and functional nutrition. The nutraceutical market in Poland exceeded €1.4 billion in 2024, with liquid supplement formats — including oral suspensions — growing at 11% CAGR, driven by convenience, faster bioavailability, and preference among elderly and young consumers.
As a full EU member, Poland follows EMA guidelines and GMP Annex 1 regulations for pharmaceutical liquid manufacturing. Polish importers and distributors require suppliers to hold ISO 22000, HACCP, and GMP certifications — all of which SINOFN fully complies with for seamless market entry.
Oral suspensions are the preferred dosage form for children aged 0–12 in Poland. Polish pediatricians and pediatric hospitals prioritize palatable, accurately dosed liquid formulations over tablets. Custom-flavored suspensions with precise active ingredient delivery are in high demand from pharmacies and healthcare providers nationwide.
Poland has a notable patient population requiring FSMP oral suspensions — particularly for metabolic disorders such as PKU (Phenylketonuria), dysphagia, and post-operative recovery. This niche but critically important segment aligns directly with SINOFN's founding mission and technical capabilities.
Poland's strategic geographic location in Central Europe makes it an ideal distribution hub for oral suspension products targeting not only the domestic market but also neighboring markets such as Germany, Czech Republic, Hungary, and the Baltic States — providing excellent logistics advantages for OEM partners.
Understanding the evolving Polish healthcare landscape helps us deliver oral suspension solutions precisely tailored to market demands, regulatory expectations, and consumer preferences.
Polish hospitals and compounding pharmacies (apteki recepturowe) increasingly demand custom oral suspension formulations tailored to individual patient needs — particularly for dose adjustments in pediatric oncology, rare metabolic diseases, and geriatric care. Our OEM customization capabilities enable Polish partners to offer truly personalized products at scale.
Polish consumers show growing preference for natural, plant-derived active ingredients in liquid supplement formats. Herbal oral suspensions featuring adaptogens, probiotics, and botanical extracts are emerging as high-growth categories in Polish health food stores and online channels. SINOFN's advanced nano-emulsion technology ensures superior bioavailability for these formulations.
Major Polish pharmacy chains including DOZ, Rossmann Health, and Hebe, as well as independent nutraceutical brands, are actively seeking reliable OEM manufacturers for private-label oral suspension products. This white-label model allows Polish distributors to build proprietary supplement lines with competitive margins and full regulatory support.
The Polish pharmaceutical industry is adopting enhanced drug delivery systems including nano-suspensions, liposomal formulations, and microencapsulation technologies. SINOFN's R&D team brings cutting-edge bioavailability optimization capabilities including nano-emulsion and UHT sterilization — directly applicable to Poland's evolving pharma and nutraceutical demand landscape.
The EU Green Deal and Polish EPR (Extended Producer Responsibility) legislation are driving demand for eco-friendly primary and secondary packaging for oral suspension products. Our full-plant integration includes BRCGS-certified packaging lines capable of accommodating recyclable glass, BPA-free plastics, and minimal-waste designs compliant with Polish retail and pharmacy requirements.
Poland has one of Europe's fastest-growing fitness communities, with over 3,700 fitness clubs and a thriving e-commerce sports nutrition market. Oral suspension formats for minerals, amino acids, collagen peptides, and energy-support blends are gaining popularity as convenient, fast-absorbing alternatives to traditional sports powders and capsules.
Science-Driven OEM for Global Supplement Brands
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group — a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
For Poland-market partners, SINOFN offers a complete one-stop solution: from custom oral suspension formulation development to GMP-certified production, quality testing, EU-compliant documentation, and direct export logistics — enabling faster time-to-market and full regulatory confidence.
From Scientific Research to Scalable Manufacturing
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children — where specialized diets were financially out of reach. Driven to bridge this gap, she founded SINOFN in 2012 to develop affordable, science-backed PKU foods.
Her commitment attracted strategic investors and fueled transformative growth:
From PKU to Global Health: Expanded into FSMP (Foods for Special Medical Purposes), clinical nutrition, and nutraceuticals.
Profit with Purpose: Dedicates a portion of revenues to PKU accessibility initiatives.
R&D Legacy: Built Tianjin R&D center with Chinese Academy of Sciences partnership.
Through cooperation with top universities and internal team building, SINOFN has established a professional scientific research team. The team includes specially appointed experts from Europe, providing unique insight into EU regulatory requirements — critical for Poland market entry and compliance.
State-of-the-art production infrastructure designed to meet the highest international standards — delivering oral suspension products that comply with EU GMP, ISO, and HACCP requirements essential for the Polish market.
10+ dedicated lines (softgels, gummies, powders, liquids)
ISO 22000, HACCP, FSSC 22000 certified
Annual capacity: 500M+ units
HPLC/GC-MS contaminant screening
Microbiological safety testing
Stability and dissolution validation
Pilot-scale prototyping for tablets/capsules/liquids
Bioavailability optimization studies
Stability testing chambers
Raw material storage → Production → Packaging
Blockchain batch tracking
BRCGS-certified warehousing
We combine scientific innovation, regulatory compliance, and scalable manufacturing to deliver custom oral suspension solutions perfectly aligned with Polish healthcare market requirements.
Joint innovation platform with the Chinese Academy of Sciences. 38 invention patents | 30% R&D team. Pioneering nano-emulsion technology for FSMP and oral suspension bioavailability — directly applicable to Poland's FSMP and clinical nutrition requirements.
Complete service from concept to finished product: oral suspensions, liquids, powders, and functional ingredients. From formulation development and pilot batch to full-scale production and EU-ready export documentation for Polish importers and distributors.
Aseptic filling · Vacuum high-shear mixing · UHT sterilization. 100+ analytical instruments | 30+ daily quality checks. Each batch undergoes comprehensive validation to meet EU pharmacopoeia and Polish GIF (Chief Pharmaceutical Inspectorate) standards.
GMP · ISO9001 · ISO22000 · HACCP · HALAL. Built for safety, consistency, and export readiness. Our certifications and documentation package is structured to facilitate smooth product registration and market authorization in Poland and across the EU.
SINOFN prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. Certified with ISO9001, ISO22000, HACCP, and HALAL — demonstrating our commitment to quality and safety for Polish and global partners.
Raw materials are assessed for compatibility, stability, and formulation integrity before production. All ingredients are verified against EU positive lists and EFSA safety assessments relevant for Polish market compliance.
Advanced processing systems maintain consistency across every manufacturing stage. Real-time monitoring of critical process parameters ensures batch-to-batch uniformity — essential for regulatory approval in Poland and the broader EU market.
Each batch is evaluated to ensure safety, stability, and specification compliance. Comprehensive Certificate of Analysis (COA) documentation is provided in formats accepted by Polish pharmaceutical authorities (Główny Inspektorat Farmaceutyczny).
Quality Liquid and Powder Supplements Range — Discover our extensive range of high-quality liquid and powder supplements designed to meet diverse Polish market needs. From raw materials to finished products, we provide comprehensive manufacturing solutions.
Key Ingredients & Components — scientifically sourced and verified active ingredients formulated for maximum efficacy, stability, and compliance with Polish and EU supplement regulations.
Ready-to-Market Offerings — fully produced, packaged, and labeled oral suspension products ready for Polish market distribution under your brand identity, complete with regulatory documentation.
Tailored to Your Brand — end-to-end custom oral suspension formulation development services, from initial concept and pilot batch through scale-up to commercial production, optimized for Polish consumer preferences.
Our full portfolio of professional oral liquid solution products — engineered for optimal bioavailability, easy administration, and compliance with Polish pharmaceutical and nutraceutical market standards.
Partner with SINOFN for science-driven oral suspension manufacturing tailored to Polish regulatory standards, local healthcare needs, and your brand vision. Get in touch today to discuss formulation requirements, MOQs, and EU export documentation.
Contact Us Now